Skip to main content

SOPHiA GENETICS SA (SOPH)

NASDAQ: SOPH · Delayed Price · USD
17.78 -0.14 (-0.78%)
Sep 21, 2021 4:00 PM EDT - Market closed
Market Cap1.11B
Revenue (ttm)29.90M
Net Income (ttm)-41.47M
Shares Out62.24M
EPS (ttm)-0.67
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,573
Open18.54
Previous Close17.92
Day's Range17.08 - 18.54
52-Week Range14.88 - 19.80
Betan/a
Analystsn/a
Price Target23.00 (+29.4%)
Est. Earnings DateNov 15, 2021

About SOPH

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. We purposefully built a cloud-based software-as-a-service (“SaaS”) platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Our platform standardizes, computes and analyzes digital health data and is used across decentralized locations to break down data silos. This enables healthcare institutions to s...

IndustryHealth Information Services
IPO DateJul 23, 2021
CEOJurgi Camblong
Employees415
Stock ExchangeNASDAQ
Ticker SymbolSOPH
Full Company Profile

Financial Performance

In 2020, SOPH's revenue was $28.40 million, an increase of 11.98% compared to the previous year's $25.36 million. Losses were -$39.34 million, 16.4% more than in 2019.

Financial Statements

News

SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance

BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021.

1 week ago - GlobeNewsWire

SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthca...

3 weeks ago - GlobeNewsWire

UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open o...

3 weeks ago - GlobeNewsWire

SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open o...

3 weeks ago - GlobeNewsWire

Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Lati...

SÃO PAULO, Brazil and BOSTON, Aug. 24, 2021 /PRNewswire/ -- Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to...

4 weeks ago - PRNewsWire

SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private Placement

BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medic...

1 month ago - GlobeNewsWire

AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know

Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company.

1 month ago - Benzinga

SOPHiA GENETICS Announces Pricing of Initial Public Offering

BOSTON and LAUSANNE, Switzerland, July 22, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced ...

1 month ago - GlobeNewsWire

SOPHiA GENETICS Announces Filing of Registration Statement for Proposed Initial Public Offering

SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today...

2 months ago - PRNewswire

SOPHiA GENETICS IPO Registration Document (S-1)

SOPHiA GENETICS SA has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC